ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fraxiparine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37A8331
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Fraxiparine Market Insights Forecast to 2028
BUY CHAPTERS

Global Fraxiparine Market Research Report 2025

Code: QYRE-Auto-37A8331
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eisai Co Ltd
Mitsubishi Tanabe Pharma Corporation
Aspen Holdings
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Bristol Myers Squibb Company
Sanofi
GlaxoSmithKline PLC
Bayer Healthcare AG.
Boehringer Ingelheim
Abbott

Fraxiparine Market

The global market for Fraxiparine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nadroparin belongs to the class of medications known as anticoagulants or antithrombotic agents. These medications reduce the clotting ability of the blood and can reduce the risk of harmful blood clots forming in blood vessels. Nadroparin is used to prevent and treat deep vein thrombosis (DVT). This condition leads to the formation of blood clots in the blood vessels in the leg. These blood clots can sometimes travel to the lungs and block blood vessels there, resulting in a serious condition known as pulmonary embolism.
North American market for Fraxiparine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fraxiparine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fraxiparine include Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Aspen Holdings, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Sanofi S.A, GlaxoSmithKline Plc, Bayer Healthcare AG, Boehringer Ingelheim, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fraxiparine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fraxiparine.
The Fraxiparine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fraxiparine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fraxiparine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fraxiparine Market Report

Report Metric Details
Report Name Fraxiparine Market
Segment by Type
  • Anticoagulant
  • Antithrombotic
Segment by Application
  • General Surgery
  • Orthopaedic Surgery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Aspen Holdings, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Sanofi S.A, GlaxoSmithKline Plc, Bayer Healthcare AG, Boehringer Ingelheim, Abbott
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fraxiparine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fraxiparine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Fraxiparine Market report?

Ans: The main players in the Fraxiparine Market are Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Aspen Holdings, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Sanofi S.A, GlaxoSmithKline Plc, Bayer Healthcare AG, Boehringer Ingelheim, Abbott

What are the Application segmentation covered in the Fraxiparine Market report?

Ans: The Applications covered in the Fraxiparine Market report are General Surgery, Orthopaedic Surgery, Others

What are the Type segmentation covered in the Fraxiparine Market report?

Ans: The Types covered in the Fraxiparine Market report are Anticoagulant, Antithrombotic

1 Fraxiparine Market Overview
1.1 Product Definition
1.2 Fraxiparine by Type
1.2.1 Global Fraxiparine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anticoagulant
1.2.3 Antithrombotic
1.3 Fraxiparine by Application
1.3.1 Global Fraxiparine Market Value by Application (2024 VS 2031)
1.3.2 General Surgery
1.3.3 Orthopaedic Surgery
1.3.4 Others
1.4 Global Fraxiparine Market Size Estimates and Forecasts
1.4.1 Global Fraxiparine Revenue 2020-2031
1.4.2 Global Fraxiparine Sales 2020-2031
1.4.3 Global Fraxiparine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fraxiparine Market Competition by Manufacturers
2.1 Global Fraxiparine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Fraxiparine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Fraxiparine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fraxiparine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fraxiparine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fraxiparine, Product Type & Application
2.7 Global Key Manufacturers of Fraxiparine, Date of Enter into This Industry
2.8 Global Fraxiparine Market Competitive Situation and Trends
2.8.1 Global Fraxiparine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fraxiparine Players Market Share by Revenue
2.8.3 Global Fraxiparine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fraxiparine Market Scenario by Region
3.1 Global Fraxiparine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fraxiparine Sales by Region: 2020-2031
3.2.1 Global Fraxiparine Sales by Region: 2020-2025
3.2.2 Global Fraxiparine Sales by Region: 2026-2031
3.3 Global Fraxiparine Revenue by Region: 2020-2031
3.3.1 Global Fraxiparine Revenue by Region: 2020-2025
3.3.2 Global Fraxiparine Revenue by Region: 2026-2031
3.4 North America Fraxiparine Market Facts & Figures by Country
3.4.1 North America Fraxiparine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fraxiparine Sales by Country (2020-2031)
3.4.3 North America Fraxiparine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fraxiparine Market Facts & Figures by Country
3.5.1 Europe Fraxiparine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fraxiparine Sales by Country (2020-2031)
3.5.3 Europe Fraxiparine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fraxiparine Market Facts & Figures by Region
3.6.1 Asia Pacific Fraxiparine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fraxiparine Sales by Region (2020-2031)
3.6.3 Asia Pacific Fraxiparine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fraxiparine Market Facts & Figures by Country
3.7.1 Latin America Fraxiparine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fraxiparine Sales by Country (2020-2031)
3.7.3 Latin America Fraxiparine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fraxiparine Market Facts & Figures by Country
3.8.1 Middle East and Africa Fraxiparine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fraxiparine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fraxiparine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fraxiparine Sales by Type (2020-2031)
4.1.1 Global Fraxiparine Sales by Type (2020-2025)
4.1.2 Global Fraxiparine Sales by Type (2026-2031)
4.1.3 Global Fraxiparine Sales Market Share by Type (2020-2031)
4.2 Global Fraxiparine Revenue by Type (2020-2031)
4.2.1 Global Fraxiparine Revenue by Type (2020-2025)
4.2.2 Global Fraxiparine Revenue by Type (2026-2031)
4.2.3 Global Fraxiparine Revenue Market Share by Type (2020-2031)
4.3 Global Fraxiparine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fraxiparine Sales by Application (2020-2031)
5.1.1 Global Fraxiparine Sales by Application (2020-2025)
5.1.2 Global Fraxiparine Sales by Application (2026-2031)
5.1.3 Global Fraxiparine Sales Market Share by Application (2020-2031)
5.2 Global Fraxiparine Revenue by Application (2020-2031)
5.2.1 Global Fraxiparine Revenue by Application (2020-2025)
5.2.2 Global Fraxiparine Revenue by Application (2026-2031)
5.2.3 Global Fraxiparine Revenue Market Share by Application (2020-2031)
5.3 Global Fraxiparine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eisai Inc
6.1.1 Eisai Inc Company Information
6.1.2 Eisai Inc Description and Business Overview
6.1.3 Eisai Inc Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eisai Inc Fraxiparine Product Portfolio
6.1.5 Eisai Inc Recent Developments/Updates
6.2 Mitsubishi Tanabe Pharma Corporation
6.2.1 Mitsubishi Tanabe Pharma Corporation Company Information
6.2.2 Mitsubishi Tanabe Pharma Corporation Description and Business Overview
6.2.3 Mitsubishi Tanabe Pharma Corporation Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mitsubishi Tanabe Pharma Corporation Fraxiparine Product Portfolio
6.2.5 Mitsubishi Tanabe Pharma Corporation Recent Developments/Updates
6.3 Aspen Holdings
6.3.1 Aspen Holdings Company Information
6.3.2 Aspen Holdings Description and Business Overview
6.3.3 Aspen Holdings Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aspen Holdings Fraxiparine Product Portfolio
6.3.5 Aspen Holdings Recent Developments/Updates
6.4 Pfizer, Inc
6.4.1 Pfizer, Inc Company Information
6.4.2 Pfizer, Inc Description and Business Overview
6.4.3 Pfizer, Inc Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer, Inc Fraxiparine Product Portfolio
6.4.5 Pfizer, Inc Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd
6.5.1 Teva Pharmaceutical Industries Ltd Company Information
6.5.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Industries Ltd Fraxiparine Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Company Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb Company Fraxiparine Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Sanofi S.A
6.7.1 Sanofi S.A Company Information
6.7.2 Sanofi S.A Description and Business Overview
6.7.3 Sanofi S.A Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi S.A Fraxiparine Product Portfolio
6.7.5 Sanofi S.A Recent Developments/Updates
6.8 GlaxoSmithKline Plc
6.8.1 GlaxoSmithKline Plc Company Information
6.8.2 GlaxoSmithKline Plc Description and Business Overview
6.8.3 GlaxoSmithKline Plc Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline Plc Fraxiparine Product Portfolio
6.8.5 GlaxoSmithKline Plc Recent Developments/Updates
6.9 Bayer Healthcare AG
6.9.1 Bayer Healthcare AG Company Information
6.9.2 Bayer Healthcare AG Description and Business Overview
6.9.3 Bayer Healthcare AG Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Healthcare AG Fraxiparine Product Portfolio
6.9.5 Bayer Healthcare AG Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Company Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boehringer Ingelheim Fraxiparine Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Abbott
6.11.1 Abbott Company Information
6.11.2 Abbott Description and Business Overview
6.11.3 Abbott Fraxiparine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Abbott Fraxiparine Product Portfolio
6.11.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fraxiparine Industry Chain Analysis
7.2 Fraxiparine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fraxiparine Production Mode & Process Analysis
7.4 Fraxiparine Sales and Marketing
7.4.1 Fraxiparine Sales Channels
7.4.2 Fraxiparine Distributors
7.5 Fraxiparine Customer Analysis
8 Fraxiparine Market Dynamics
8.1 Fraxiparine Industry Trends
8.2 Fraxiparine Market Drivers
8.3 Fraxiparine Market Challenges
8.4 Fraxiparine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eisai Co Ltd
Mitsubishi Tanabe Pharma Corporation
Aspen Holdings
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Bristol Myers Squibb Company
Sanofi
GlaxoSmithKline PLC
Bayer Healthcare AG.
Boehringer Ingelheim
Abbott
List of Tables
 Table 1. Global Fraxiparine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Fraxiparine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Fraxiparine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Fraxiparine Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Fraxiparine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Fraxiparine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Fraxiparine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Fraxiparine Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Fraxiparine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Fraxiparine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Fraxiparine, Product Type & Application
 Table 12. Global Key Manufacturers of Fraxiparine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fraxiparine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fraxiparine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fraxiparine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Fraxiparine Sales by Region (2020-2025) & (MT)
 Table 18. Global Fraxiparine Sales Market Share by Region (2020-2025)
 Table 19. Global Fraxiparine Sales by Region (2026-2031) & (MT)
 Table 20. Global Fraxiparine Sales Market Share by Region (2026-2031)
 Table 21. Global Fraxiparine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Fraxiparine Revenue Market Share by Region (2020-2025)
 Table 23. Global Fraxiparine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Fraxiparine Revenue Market Share by Region (2026-2031)
 Table 25. North America Fraxiparine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Fraxiparine Sales by Country (2020-2025) & (MT)
 Table 27. North America Fraxiparine Sales by Country (2026-2031) & (MT)
 Table 28. North America Fraxiparine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Fraxiparine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Fraxiparine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Fraxiparine Sales by Country (2020-2025) & (MT)
 Table 32. Europe Fraxiparine Sales by Country (2026-2031) & (MT)
 Table 33. Europe Fraxiparine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Fraxiparine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Fraxiparine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Fraxiparine Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Fraxiparine Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Fraxiparine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Fraxiparine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fraxiparine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Fraxiparine Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Fraxiparine Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Fraxiparine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Fraxiparine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Fraxiparine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Fraxiparine Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Fraxiparine Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Fraxiparine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Fraxiparine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Fraxiparine Sales (MT) by Type (2020-2025)
 Table 51. Global Fraxiparine Sales (MT) by Type (2026-2031)
 Table 52. Global Fraxiparine Sales Market Share by Type (2020-2025)
 Table 53. Global Fraxiparine Sales Market Share by Type (2026-2031)
 Table 54. Global Fraxiparine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Fraxiparine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Fraxiparine Revenue Market Share by Type (2020-2025)
 Table 57. Global Fraxiparine Revenue Market Share by Type (2026-2031)
 Table 58. Global Fraxiparine Price (US$/g) by Type (2020-2025)
 Table 59. Global Fraxiparine Price (US$/g) by Type (2026-2031)
 Table 60. Global Fraxiparine Sales (MT) by Application (2020-2025)
 Table 61. Global Fraxiparine Sales (MT) by Application (2026-2031)
 Table 62. Global Fraxiparine Sales Market Share by Application (2020-2025)
 Table 63. Global Fraxiparine Sales Market Share by Application (2026-2031)
 Table 64. Global Fraxiparine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Fraxiparine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Fraxiparine Revenue Market Share by Application (2020-2025)
 Table 67. Global Fraxiparine Revenue Market Share by Application (2026-2031)
 Table 68. Global Fraxiparine Price (US$/g) by Application (2020-2025)
 Table 69. Global Fraxiparine Price (US$/g) by Application (2026-2031)
 Table 70. Eisai Inc Company Information
 Table 71. Eisai Inc Description and Business Overview
 Table 72. Eisai Inc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Eisai Inc Fraxiparine Product
 Table 74. Eisai Inc Recent Developments/Updates
 Table 75. Mitsubishi Tanabe Pharma Corporation Company Information
 Table 76. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
 Table 77. Mitsubishi Tanabe Pharma Corporation Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Mitsubishi Tanabe Pharma Corporation Fraxiparine Product
 Table 79. Mitsubishi Tanabe Pharma Corporation Recent Developments/Updates
 Table 80. Aspen Holdings Company Information
 Table 81. Aspen Holdings Description and Business Overview
 Table 82. Aspen Holdings Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Aspen Holdings Fraxiparine Product
 Table 84. Aspen Holdings Recent Developments/Updates
 Table 85. Pfizer, Inc Company Information
 Table 86. Pfizer, Inc Description and Business Overview
 Table 87. Pfizer, Inc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. Pfizer, Inc Fraxiparine Product
 Table 89. Pfizer, Inc Recent Developments/Updates
 Table 90. Teva Pharmaceutical Industries Ltd Company Information
 Table 91. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 92. Teva Pharmaceutical Industries Ltd Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceutical Industries Ltd Fraxiparine Product
 Table 94. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Company Information
 Table 96. Bristol-Myers Squibb Company Description and Business Overview
 Table 97. Bristol-Myers Squibb Company Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb Company Fraxiparine Product
 Table 99. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 100. Sanofi S.A Company Information
 Table 101. Sanofi S.A Description and Business Overview
 Table 102. Sanofi S.A Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. Sanofi S.A Fraxiparine Product
 Table 104. Sanofi S.A Recent Developments/Updates
 Table 105. GlaxoSmithKline Plc Company Information
 Table 106. GlaxoSmithKline Plc Description and Business Overview
 Table 107. GlaxoSmithKline Plc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline Plc Fraxiparine Product
 Table 109. GlaxoSmithKline Plc Recent Developments/Updates
 Table 110. Bayer Healthcare AG Company Information
 Table 111. Bayer Healthcare AG Description and Business Overview
 Table 112. Bayer Healthcare AG Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Bayer Healthcare AG Fraxiparine Product
 Table 114. Bayer Healthcare AG Recent Developments/Updates
 Table 115. Boehringer Ingelheim Company Information
 Table 116. Boehringer Ingelheim Description and Business Overview
 Table 117. Boehringer Ingelheim Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. Boehringer Ingelheim Fraxiparine Product
 Table 119. Boehringer Ingelheim Recent Developments/Updates
 Table 120. Abbott Company Information
 Table 121. Abbott Description and Business Overview
 Table 122. Abbott Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 123. Abbott Fraxiparine Product
 Table 124. Abbott Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Fraxiparine Distributors List
 Table 128. Fraxiparine Customers List
 Table 129. Fraxiparine Market Trends
 Table 130. Fraxiparine Market Drivers
 Table 131. Fraxiparine Market Challenges
 Table 132. Fraxiparine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fraxiparine
 Figure 2. Global Fraxiparine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fraxiparine Market Share by Type: 2024 & 2031
 Figure 4. Anticoagulant Product Picture
 Figure 5. Antithrombotic Product Picture
 Figure 6. Global Fraxiparine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Fraxiparine Market Share by Application: 2024 & 2031
 Figure 8. General Surgery
 Figure 9. Orthopaedic Surgery
 Figure 10. Others
 Figure 11. Global Fraxiparine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Fraxiparine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Fraxiparine Sales (2020-2031) & (MT)
 Figure 14. Global Fraxiparine Average Price (US$/g) & (2020-2031)
 Figure 15. Fraxiparine Report Years Considered
 Figure 16. Fraxiparine Sales Share by Manufacturers in 2024
 Figure 17. Global Fraxiparine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Fraxiparine Players: Market Share by Revenue in Fraxiparine in 2024
 Figure 19. Fraxiparine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Fraxiparine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Fraxiparine Sales Market Share by Country (2020-2031)
 Figure 22. North America Fraxiparine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Fraxiparine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Fraxiparine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Fraxiparine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Fraxiparine Revenue Market Share by Region (2020-2031)
 Figure 34. China Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Fraxiparine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Fraxiparine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Fraxiparine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Fraxiparine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Fraxiparine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Fraxiparine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Fraxiparine by Type (2020-2031)
 Figure 55. Global Fraxiparine Price (US$/g) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Fraxiparine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Fraxiparine by Application (2020-2031)
 Figure 58. Global Fraxiparine Price (US$/g) by Application (2020-2031)
 Figure 59. Fraxiparine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Nadroparin Calcium Market Research Report 2024
Global Nadroparin Calcium Injection Market Research Report 2024
Rivaroxaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rivaroxaban Drugs Market Research Report 2024
Global Heparin Market Insights Forecast to 2030
Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Factor Xa Inhibitors Market Research Report 2024
Global Anticoagulant Medicines Market Research Report 2025
Global Factor Xa Inhibitors Market Research Report 2024
Global Rivaroxaban Tablets Market Research Report 2024
Global Direct Thrombin Inhibitors DTIs Market Research Report 2024
Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enoxaparin API Market Research Report 2025
Global Enoxaparin Sodium Market Research Report 2024
Global Dabigatran Etexilate Drugs Market Research Report 2024
Hypercoagulation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Anticoagulant Market Insights Forecast to 2028
Global Thrombosis Drug Market Research Report 2025
Global Anticoagulant Reversal Agent Market Research Report 2024
Global Porcine Heparin APIs Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions